Eye drug Eylea has mysterious rise in side effect reports
Minneapolis
DOCTORS say they're seeing an unexplained increase in a rare, frightening side effect in patients getting Regeneron Pharmaceuticals' top-selling product, the blockbuster eye drug Eylea.
After the drug is injected into the eye, a small number of people have a sharp decline in sight, experience pain, and can panic. While the effect is treatable and doesn't lead to long-term vision loss, a professional society of eye physicians has warned members to look out for the condition.
The company said it's closely monitoring the reports, which are a known complication of Eylea and its rivals.
In the past, occasional clusters of cases, linked to inflammation, have been reported …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Lululemon to shutter Washington distribution center, lay off 128 employees
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
P&G raises annual core profit forecast on resilient demand, price hikes
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up